New European Regulation on Clinical Trials, rules and implementation, where are we?

- 29 mai 2019

New European Regulation on Clinical Trials, rules and implementation, where are we?

 

Clinical Trials (CT) are currently regulated under the Directive 2001/20/EC. The Directive had a positive impact on the safety, ethic and reliability of data from CT. However, limitations were soon evidenced such as a decreased number of CT in Europe, increased costs and length of the procedure. Therefore, the European Commission decided to replace the Directive by a new Regulation, the “ Regulation EU No 536/2014”, with the aim of restoring the competitiveness in Europe by simplifying and harmonising the requirements.

 

In this White paper we discuss the main differences between the CT Directive and the CT Regulation and its implementation steps. We also investigate how Member States are implementing the Regulation : either by pilot phases and/or transposition into national laws. And finally, how can we, as Sponsor, get ready for this Regulation ?

Vous avez aimé cet article ? Partagez le sur les réseaux sociaux :

Download the
White Paper


BlueReg undertakes to comply with the regulations in force applicable to the processing of personal data and, in particular, Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 applicable as from 25 May 2018 (hereinafter, "the General Data Protection Regulations" or GPDR) and the national laws resulting therefrom.
Any inquiries, correction or declaration of event related to personal data processed should be sent to: br-dataprivacy@blue-reg.com
Learn more

Thank you for your reply

You can download the file below

Télécharger

Découvrez notre dernier livre blanc

En savoir plus